Escientia Life Sciences is a leading development and manufacturing partner to innovative pharmaceuticals and biotechnology companies. Founded in 2007 by Dr. Yadagiri Pendri, the company is at the cutting-edge of continuous processing, green chemistry, and increased reliability in pharmaceutical manufacturing. With its global headquarters and research laboratories in South Windsor, Connecticut, United States, and a development hub in Hyderabad, Telangana, and a state-of-the-art pharmaceutical manufacturing park in Vizag, Andhra Pradesh, both in India, Escientia is well-positioned to serve its global clientele.
As a premier American technology-oriented manufacturing partner, Escientia has established itself as a preferred partner to the largest and most innovative pharma and biotech companies, as well as governments seeking to secure critical supply chains. The company's co-founder and President, Kiran Pendri, leads Escientia's efforts to constantly expand its capabilities and capacity.
Escientia's impactful presence in the Biotechnology, Manufacturing, and Pharmaceutical industries, along with its commitment to leveraging modern science and engineering, makes it a compelling investment opportunity in the life sciences sector. With a skilled leadership team and a track record of success over the past 15 years, Escientia offers an attractive proposition for potential venture capital investors seeking exposure to the evolving landscape of pharmaceutical manufacturing and development.
There is no investment information
No recent news or press coverage available for Escientia Life Sciences.